116 – Real-World Evidence Impact (S8E11)

From Concept to Medicine - A Comprehensive Drug Development Journey

This episode delves into the increasing importance of real-world evidence (RWE) in informing post-approval drug safety and effectiveness assessments. We discuss key data sources, including electronic health records (EHRs), insurance claims data, patient registries, and even social media. Analytical platforms, such as AI-driven signal detection and machine learning models, are explored.

The conversation highlights how RWE influences regulatory decisions, label updates, and the development of risk mitigation strategies. Real-world case studies from post-market surveillance programs are used to illustrate the practical impact of RWE. The episode also touches on the ethical considerations and challenges associated with using RWE, such as data privacy and ensuring the accuracy and reliability of algorithms.

More description

This episode delves into the increasing importance of real-world evidence (RWE) in informing post-approval drug safety and effectiveness assessments. We discuss key data sources, including electronic health records (EHRs), insurance claims data, patient registries, and even social media. Analytical platforms, such as AI-driven signal detection and machine learning models, are explored.

The conversation highlights how RWE influences regulatory decisions, label updates, and the development of risk mitigation strategies. Real-world case studies from post-market surveillance programs are used to illustrate the practical impact of RWE. The episode also touches on the ethical considerations and challenges associated with using RWE, such as data privacy and ensuring the accuracy and reliability of algorithms.

2025-05-04 11 min Transcript
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.